NPI: 1306897335 · FORT WAYNE, IN 46804 · Ambulatory Surgical Clinic/Center · NPI assigned 05/15/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 05/15/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 69,779 | $1.77M |
| 2019 | 60,662 | $2.77M |
| 2020 | 66,720 | $3.31M |
| 2021 | 77,036 | $5.47M |
| 2022 | 81,866 | $6.84M |
| 2023 | 65,898 | $5.40M |
| 2024 | 27,201 | $1.95M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 55,795 | 47,125 | $9.12M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 44,231 | 34,598 | $6.65M |
| 71045 | Radiologic examination, chest; single view | 13,465 | 10,243 | $1.79M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,865 | 1,340 | $1.08M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7,363 | 6,403 | $885K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7,111 | 5,130 | $878K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 14,835 | 10,309 | $846K |
| A0425 | Ground mileage, per statute mile | 9,987 | 7,783 | $776K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 5,561 | 4,471 | $420K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6,156 | 5,132 | $415K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | 3,539 | 2,757 | $359K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,078 | 723 | $328K |
| 71046 | Radiologic examination, chest; 2 views | 3,513 | 2,913 | $296K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8,372 | 7,190 | $243K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,641 | 1,897 | $239K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 181 | 111 | $200K |
| 16020 | 926 | 448 | $183K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 40,269 | 28,153 | $177K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13,507 | 7,125 | $176K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,901 | 1,413 | $166K |
| 97602 | 1,769 | 584 | $165K | |
| 80053 | Comprehensive metabolic panel | 23,181 | 16,657 | $138K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 154 | 127 | $138K |
| 99218 | 436 | 242 | $136K | |
| 93304 | 230 | 187 | $134K | |
| 74018 | 933 | 783 | $131K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,446 | 1,526 | $121K |
| 36415 | Collection of venous blood by venipuncture | 55,465 | 37,248 | $110K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9,088 | 7,281 | $105K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 296 | 181 | $98K |
| 80050 | General health panel | 909 | 748 | $90K |
| 99217 | 183 | 139 | $77K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,488 | 3,484 | $60K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 521 | 454 | $58K |
| 99221 | 126 | 96 | $51K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 138 | 108 | $49K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 769 | 345 | $43K |
| 84484 | 7,267 | 4,308 | $42K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 624 | 522 | $40K |
| 87430 | 3,144 | 2,714 | $35K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,016 | 653 | $33K |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,566 | 6,039 | $32K |
| G0378 | Hospital observation service, per hour | 364 | 175 | $24K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 662 | 359 | $23K |
| 72125 | Computed tomography, cervical spine; without contrast material | 177 | 123 | $21K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,973 | 2,290 | $19K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 223 | 200 | $18K |
| 81001 | 9,312 | 7,175 | $18K | |
| 81025 | 2,742 | 2,236 | $16K | |
| 83690 | 5,210 | 3,863 | $15K | |
| 87807 | 1,584 | 1,392 | $15K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,085 | 841 | $12K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 598 | 288 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | 935 | 762 | $10K |
| 85027 | 5,160 | 3,622 | $10K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 102 | 29 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,183 | 992 | $8K |
| 0240U | 99 | 83 | $8K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 106 | 76 | $7K |
| 82728 | 593 | 490 | $7K | |
| 87428 | 208 | 172 | $6K | |
| 83735 | 2,265 | 1,293 | $6K | |
| 84703 | 1,106 | 831 | $5K | |
| 82947 | 4,428 | 2,785 | $5K | |
| 80051 | 3,039 | 2,208 | $5K | |
| 97803 | 48 | 43 | $5K | |
| 80061 | Lipid panel | 667 | 511 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,005 | 801 | $4K |
| 81003 | 4,499 | 3,472 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 147 | 110 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 147 | 110 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 147 | 122 | $4K |
| 82565 | 3,069 | 2,220 | $4K | |
| 82248 | 1,112 | 565 | $4K | |
| 80076 | 1,353 | 1,054 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 213 | 176 | $3K |
| 93321 | 392 | 324 | $3K | |
| 82247 | 964 | 461 | $3K | |
| 84520 | 3,038 | 2,208 | $3K | |
| 94010 | 31 | 27 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 103 | 67 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 129 | 115 | $3K |
| 84460 | 787 | 405 | $3K | |
| 84450 | 787 | 405 | $3K | |
| 84075 | 787 | 405 | $3K | |
| 88342 | 174 | 137 | $2K | |
| 86001 | 28 | 25 | $2K | |
| 85610 | 1,180 | 794 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 20 | 14 | $2K |
| 80197 | 690 | 315 | $2K | |
| 87641 | 259 | 172 | $2K | |
| 36591 | 223 | 51 | $2K | |
| 84439 | 181 | 161 | $1K | |
| 88312 | 262 | 190 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 35 | 29 | $1K |
| 85730 | 546 | 378 | $1K | |
| 99220 | 35 | 15 | $1K | |
| 82550 | 910 | 441 | $1K | |
| 83605 | 221 | 153 | $918.89 | |
| 85046 | 186 | 157 | $895.29 | |
| 82570 | 890 | 410 | $878.14 | |
| 83516 | 69 | 51 | $858.93 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 121 | 89 | $824.71 |
| 83880 | 59 | 39 | $790.18 | |
| 84550 | 840 | 380 | $695.42 | |
| 84100 | 556 | 361 | $624.87 | |
| 84156 | 890 | 411 | $619.26 | |
| 85045 | 137 | 117 | $584.84 | |
| 82607 | 73 | 51 | $557.96 | |
| 82746 | 73 | 51 | $543.90 | |
| 73630 | 12 | 12 | $512.55 | |
| 82150 | 92 | 66 | $498.30 | |
| 82330 | 77 | 54 | $407.66 | |
| 83540 | 124 | 96 | $403.08 | |
| 86255 | 30 | 25 | $389.62 | |
| 87040 | 69 | 29 | $368.42 | |
| 96376 | 91 | 27 | $294.84 | |
| 87210 | 64 | 53 | $292.03 | |
| 87799 | 14 | 12 | $285.91 | |
| 82657 | 54 | 15 | $259.44 | |
| 84481 | 13 | 13 | $229.92 | |
| 86140 | 47 | 39 | $198.68 | |
| 87081 | 31 | 30 | $192.27 | |
| 83550 | 47 | 42 | $186.20 | |
| 87070 | 41 | 36 | $168.67 | |
| 82784 | 15 | 13 | $143.91 | |
| 90744 | 179 | 150 | $110.12 | |
| 88302 | 84 | 79 | $96.90 | |
| 93325 | 392 | 324 | $84.43 | |
| 87205 | 16 | 12 | $48.42 | |
| J2704 | Injection, propofol, 10 mg | 3,532 | 2,182 | $23.76 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,062 | 2,453 | $0.49 |
| J7030 | Infusion, normal saline solution , 1000 cc | 596 | 534 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,558 | 2,009 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 28 | 25 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 600 | 455 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 182 | 152 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 80 | 38 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 87 | 77 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 130 | 110 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 69 | 49 | $0.00 |
| A9270 | Non-covered item or service | 59 | 53 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 47 | 29 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 205 | 174 | $0.00 |
| 90686 | 17 | 15 | $0.00 | |
| J3490 | Unclassified drugs | 17 | 15 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 27 | 26 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 14 | 14 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 23 | 12 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 16 | 12 | $0.00 |
| 90688 | 39 | 33 | $0.00 |